Related Experiment Video

Updated: Jul 16, 2026

Analysis of Gene Expression Changes in the Rat Hippocampus After Deep Brain Stimulation of the Anterior Thalamic Nucleus
09:46

Analysis of Gene Expression Changes in the Rat Hippocampus After Deep Brain Stimulation of the Anterior Thalamic Nucleus

Published on: March 8, 2015

Review: new biological insights in early clinical studies

Michela Maur1, Cristiana Sessa

  • 1Oncology and Haematology Department, University Study of Modena and Reggio Emilia, Italy.

Hematological Oncology
|March 14, 2007
PubMed

Insights

First in human phase I trials are crucial for developing new anticancer therapies. This review covers biological, methodological, and design aspects of early clinical studies for targeted therapies.

Area of Science:

  • Oncology
  • Clinical Pharmacology
  • Drug Development

Background:

  • First in human phase I trials are essential for advancing novel anticancer therapies.
  • The advent of targeted therapies has transformed clinical drug development paradigms.
  • Early clinical studies are critical for evaluating the safety and efficacy of new cancer treatments.

Purpose of the Study:

  • To review key features of early clinical studies for anticancer therapies.
  • To highlight the importance of biological understanding in trial design.
  • To discuss methodological and design considerations for phase I trials.

Main Methods:

  • Review of literature on early-phase clinical trials.
  • Analysis of trial design elements in targeted therapy development.
  • Examination of biological rationale and patient selection criteria.

Main Results:

  • Phase I trials require a deep understanding of tumor biology.
  • Methodological rigor and adequate study design are paramount for success.
  • Effective performance of early clinical studies ensures reliable data for further development.

Conclusions:

  • Optimizing early clinical studies is vital for the successful development of anticancer drugs.
  • A comprehensive approach integrating biology, methodology, and design enhances trial outcomes.
  • Well-designed phase I trials accelerate the delivery of innovative cancer therapies to patients.

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...